Siolta: Seeding the microbiome

How Siolta’s bacterial cocktail could prevent the onset of asthma in infants

Backed by Khosla Ventures and about a decade of research connecting the microbiome to allergic diseases, Siolta Therapeutics Inc. has its bacterial cocktail in a Phase I trial to prevent the onset of asthma in newborns along with a companion diagnostic for the disease.

Siolta co-founders Susan Lynch and Nikole Kimes met when Kimes joined Lynch’s lab as a postdoc at University of California San Francisco, where Lynch is an

Read the full 699 word article

How to gain access

Continue reading with a
two-week free trial.